Edesa Biotech Inc. (NASDAQ: EDSA) will present data on its experimental drug paridiprubart for acute kidney injury at the 63rd ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE